HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine combo shows promise for tough bladder cancer
Disease control Recruiting nowThis early-phase trial tests a new vaccine (IO102-IO103) plus the immunotherapy drug pembrolizumab in 30 adults with a type of bladder cancer that did not respond to or could not tolerate standard BCG therapy. The vaccine aims to train the body's immune cells to recognize and att…
Matched conditions: HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
Could one surgery be enough? new trial aims to cut unnecessary procedures for bladder cancer patients
Disease control Recruiting nowThis study compares a newer, single surgery using special dye and light (PDD-TURBT) against the standard approach of two surgeries for early-stage bladder cancer. About 112 adults with non-muscle invasive bladder cancer will be randomly assigned to either the new single-surgery m…
Matched conditions: HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated May 18, 2026 12:09 UTC